Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5207426
Max Phase: Preclinical
Molecular Formula: C19H12ClN3O3
Molecular Weight: 365.78
Associated Items:
ID: ALA5207426
Max Phase: Preclinical
Molecular Formula: C19H12ClN3O3
Molecular Weight: 365.78
Associated Items:
Canonical SMILES: N#Cc1cc(-c2ncc(C(=O)O)cn2)ccc1OCc1ccc(Cl)cc1
Standard InChI: InChI=1S/C19H12ClN3O3/c20-16-4-1-12(2-5-16)11-26-17-6-3-13(7-14(17)8-21)18-22-9-15(10-23-18)19(24)25/h1-7,9-10H,11H2,(H,24,25)
Standard InChI Key: ZFDLCRWMTXDSMU-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 365.78 | Molecular Weight (Monoisotopic): 365.0567 | AlogP: 3.95 | #Rotatable Bonds: 5 |
Polar Surface Area: 96.10 | Molecular Species: ACID | HBA: 5 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.84 | CX Basic pKa: 1.02 | CX LogP: 3.92 | CX LogD: 0.64 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.74 | Np Likeness Score: -1.29 |
1. Zhao J, Mao Q, Lin F, Zhang B, Sun M, Zhang T, Wang S.. (2022) Intramolecular hydrogen bond interruption and scaffold hopping of TMC-5 led to 2-(4-alkoxy-3-cyanophenyl)pyrimidine-4/5-carboxylic acids and 6-(4-alkoxy-3-cyanophenyl)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-ones as potent pyrimidine-based xanthine oxidase inhibitors., 229 [PMID:34992040] [10.1016/j.ejmech.2021.114086] |
Source(1):